2019
DOI: 10.1177/2515841419831152
|View full text |Cite
|
Sign up to set email alerts
|

Polypoidal choroidal vasculopathy: a comprehensive clinical update

Abstract: Polypoidal choroidal vasculopathy as a disease is yet to be comprehended completely. The clinical features consisting of huge serosanguineous retinal pigment epithelial and neurosensory layer detachments, although unique may closely mimick neovascular age-related macular degeneration and other counterparts. The investigative modalities starting from indocyanine angiography to optical coherence tomography angiography provide diagnostic challenges. The management strategies based on the available therapies are p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
41
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 27 publications
(43 citation statements)
references
References 161 publications
1
41
1
Order By: Relevance
“…A study based on biomicroscopy of PCV supported the similar mechanism of compression effect from a sclerosed vessel in branch retinal vein occlusion (BRVO), causing vascular fragility, degeneration, polypoidal formation, vascular leakage, and hemorrhage [9]. In addition, the presence of polyps in the early phase and leakage in the late phase in an ICGA further enhanced this theory [4,9].…”
Section: Discussionmentioning
confidence: 88%
See 2 more Smart Citations
“…A study based on biomicroscopy of PCV supported the similar mechanism of compression effect from a sclerosed vessel in branch retinal vein occlusion (BRVO), causing vascular fragility, degeneration, polypoidal formation, vascular leakage, and hemorrhage [9]. In addition, the presence of polyps in the early phase and leakage in the late phase in an ICGA further enhanced this theory [4,9].…”
Section: Discussionmentioning
confidence: 88%
“…The prevalence of ODD is very low and their association with CNV and PCV is extremely rare, with no established treatment regimen [4]. The management of PCV varies according to the clinical-pathological manifestations of the disease.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Various systemic risk factors have been associated with PCV to varying degrees [1,9,41]. Among them, systemic arterial hypertension (HTN) has been singled out in some reports with proportions of patients with HTN ranging between 20% and 70% [30,[36][37][38][39][42][43][44][45][46][47].…”
Section: Discussionmentioning
confidence: 99%
“…Polypoidal choroidal vasculopathy (PCV) is a distinct clinical entity characterized by polypoidal abnormalities of vessels originating from the choroid, also described as aneurismal type 1 neovascularization in the literature [ 1 , 2 ]. It is an important differential diagnosis to neovascular age-related macular degeneration (AMD) since the accepted standard treatment of neovascular AMD is monotherapy using intravitreal injections of vascular endothelial growth factor inhibitors (anti-VEGF), whereas the accepted standard treatment of PCV is based on a combination therapy using and full-dose photodynamic therapy to achieve polyp closure and anti-VEGF [ 1 , 3 , 4 ]. In some cases, monotherapy with either photodynamic therapy or anti-VEGF may suffice for PCV.…”
Section: Introductionmentioning
confidence: 99%